Jasti Group Executes Inter-Se Stake Transfer in Cohance Lifesciences
Cohance Lifesciences Ltd 路 Acquisition/ Disposal of Shares 路 11 Nov 2026, 10:11 pm
Jasti Group Executes Inter-Se Stake Transfer in Cohance Lifesciences Jasti Property and Equity Holdings Private Limited disclosed an inter-se transfer of 51,00,000 equity shares (1.33% total voting capital, 1.26% diluted) of Cohance Lifesciences Limited via block deals on 9th Nov'26 and 11th Nov'26. Jasti Property reduced its direct holding from 2.51% (96,16,009 shares) to 1.18% (45,16,009 shares), while PAC Jasub Property Holdings LLP increased its stake from 3.84% to 5.18% (1,98,00,000 shares). Aggregate PAC group holding remained unchanged at 6.36% (2,43,26,009 shares) of voting capital and 5.99% on a diluted basis across 38,25,67,140 total shares.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
- Audio link for the conference call 路 07 Nov 2026
